Literature DB >> 4121926

Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator.

E H Vallota, H J Müller-Eberhard.   

Abstract

Two biologically and chemically distinct anaphylatoxins (ATs) could be generated in whole human serum after removal of the AT inactivator (AI) by immune-absorption or after inhibition of AI with 1 M epsilon-aminocaproic acid (EACA). Both human ATs could be generated by treatment of serum with antigen-antibody complexes, which activate the classical complement pathway, and with inulin or yeast, both of which trigger the alternate pathway. The ATs were isolated from serum in active form and characterized as C3a and C5a. Although human C3a had been characterized previously, C5a had not. The molecular weight of human C5a AT was 17,500; its electrophoretic mobility at pH 8.5 was -1.7 x 10(-5) cm(2) V(-1) s(-1). The minimal effective concentration in vitro was 7.5 x 10(-10) M. The minimal effective doses of human C5a in producing a wheal and erythema in the human skin was 1 x 10(-15) mol. The results strongly suggest a biological function for both ATs and indicate that the expression of their activity is controlled by the AI of normal blood plasma.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4121926      PMCID: PMC2139248          DOI: 10.1084/jem.137.5.1109

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

2.  Antigenic determinants of human beta-1c and beta-1g-globulins.

Authors:  C West; N C Davis; J Forristal; J Herbst; R Spitzer
Journal:  J Immunol       Date:  1966-04       Impact factor: 5.422

3.  Biologically active water-insoluble protein polymers. I. Their use for isolation of antigens and antibodies.

Authors:  S Avrameas; T Ternynck
Journal:  J Biol Chem       Date:  1967-04-10       Impact factor: 5.157

4.  Size and charge isomer separation and estimation of molecular weights of proteins by disc gel electrophoresis.

Authors:  J L Hedrick; A J Smith
Journal:  Arch Biochem Biophys       Date:  1968-07       Impact factor: 4.013

5.  The gel-filtration behaviour of proteins related to their molecular weights over a wide range.

Authors:  P Andrews
Journal:  Biochem J       Date:  1965-09       Impact factor: 3.857

6.  Second kininase in human blood plasma.

Authors:  H Y Yang; E G Erdös
Journal:  Nature       Date:  1967-09-23       Impact factor: 49.962

7.  Anaphylatoxin in its relation to the complement system.

Authors:  J Jensen
Journal:  Science       Date:  1967-03-03       Impact factor: 47.728

8.  Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3.

Authors:  W D da Silva; J W Eisele; I H Lepow
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307

9.  The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.

Authors:  C G Cochrane; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1968-02-01       Impact factor: 14.307

10.  Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.

Authors:  V A Bokisch; H J Müller-Eberhard; C G Cochrane
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

View more
  47 in total

1.  Demonstration of a factor in the serum of homozygotes and heterozygotes for cystic fibrosis by a non-biological technique.

Authors:  K Altland; S R Schmidt; G Kaiser; W Knoche
Journal:  Humangenetik       Date:  1975-07-23

2.  Effect of hog anaphylatoxin (C 5a) on vascular permeability and leukocyte emigration in vivo.

Authors:  B Damerau; W Vogt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-12       Impact factor: 3.000

3.  Fast deactivation of guinea-pig isolated ileum to C5adesArg: a possible cyclic AMP-dependent mechanism.

Authors:  B Damerau; J Roesler; W Vogt
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

4.  Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release.

Authors:  E S Schulman; T J Post; P M Henson; P C Giclas
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

5.  Interactions of radio-detoxified Escherichia coli endotoxin preparations with the complement system.

Authors:  G Füst; L Bertók; S Juhász-Nagy
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

6.  Mechanisms of lysosomal enzyme release from human leukocytes: microtubule assembly and membrane fusion induced by a component of complement.

Authors:  I Goldstein; S Hoffstein; J Gallin; G Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

Review 7.  Structure and function of the anaphylatoxins.

Authors:  T E Hugli
Journal:  Springer Semin Immunopathol       Date:  1984

8.  Acute lung inflammation induced in the rabbit by local instillation of 1-0-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine or of native platelet-activating factor.

Authors:  G Camussi; I Pawlowski; C Tetta; C Roffinello; M Alberton; J Brentjens; G Andres
Journal:  Am J Pathol       Date:  1983-07       Impact factor: 4.307

9.  In vivo and in vitro effects of dexamethasone on leukocyte migration in the rat adjuvant arthritis model.

Authors:  T R Thieme; A Mirkovich; P Maloney; D A Goodwin
Journal:  Inflammation       Date:  1982-12       Impact factor: 4.092

10.  Evidence of complement catabolism in experimental acute pancreatitis.

Authors:  J K Horn; J H Ranson; I M Goldstein; J Weissler; D Curatola; R Taylor; H D Perez
Journal:  Am J Pathol       Date:  1980-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.